Drugs / PUR0200
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02671825 | Jan → Mar 2016 | — | Pulmatrix Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01921712 | Jul → Dec 2013 | chronic obstructive pulmonary disease | Pulmatrix Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PUR0200 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01921712 ↗ |
| Route | Inhaled | “PUR0200 low dose, single dose inhalation” NCT01921712 ↗ |